Effects of Neural Mobilization on Respiratory Parameters in Chronic Neck Pain

NCT ID: NCT05867082

Last Updated: 2024-08-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

26 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-06-26

Study Completion Date

2023-10-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Objective: Neural mobilization (NM) is commonly used to treat nerve disorders, and it is useful for disorders associated with neck and arm pain. This study aimed to determine the effects of NM on respiratory function in patients with chronic neck pain.

Methods: Overall, 26 patients with neck pain were randomly assigned to two groups: NM or control. In these participants, respiratory function and active cervical range of motion were assessed before and after intervention. Furthermore, the participants were provided a visual analog scale (VAS) and Fremantle Neck Awareness Questionnaire (FreNAQ). Each participant underwent 15 treatment sessions (5 days per week for 3 weeks). Further, in the NM group, in addition to conventional treatment, 10 sessions of neural mobilization were performed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neck Pain Respiratory

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Neural Mobilization Group

Each participant underwent 15 treatment sessions (5 days per week for 3 weeks). Further, in the NM group, in addition to conventional treatment, 10 sessions of neural mobilization were performed.

Group Type EXPERIMENTAL

Neural Mobilization

Intervention Type OTHER

Radial Nerve Mobilization, Medial Mobilization, Ulnar Mobilization

Control Group

Each participant underwent 15 treatment sessions (5 days per week for 3 weeks).

Group Type EXPERIMENTAL

Neural Mobilization

Intervention Type OTHER

Radial Nerve Mobilization, Medial Mobilization, Ulnar Mobilization

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neural Mobilization

Radial Nerve Mobilization, Medial Mobilization, Ulnar Mobilization

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals aged 25-65 years,
* those with neck pain for \>3 months
* those with complaints of pain, tension
* numbness on neurodynamic nerve tests

Exclusion Criteria

* individuals with spinal stenosis,
* neurological diagnosis, malignancy,
* upper extremity vascular problems,
* osteoporosis,
* pregnancy,
* history of newly repaired peripheral nerves,
* inflammatory processes,
* cervical spine and upper extremity surgeries,
* conditions affecting lung capacity (such as asthma, bronchitis, and diabetes mellitus)
Minimum Eligible Age

25 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Okan University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emine Atıcı

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Elif Tunç, Msc

Role: STUDY_DIRECTOR

Medical Park Gebze Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical Park Gebze Hosptal

Gebze, Kocaeli, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.